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Several associations have been made between characteristics of the resident gut
microbiota and human health and disease susceptibility. Animal models provide the
means to test these correlations prospectively and evaluate causality. Experimental
fecal microbiota transfer (FMT), or the intentional transplantation of gut microbes into
recipient mice depleted of their autochthonous microbes with antibiotics, is a commonly
used method of testing these relationships. The true completeness of microbial transfer
through such procedures is poorly documented in the literature, particularly in the context
of reciprocal transfer of microbes between recipient and donor mice harboring microbial
populations of differing richness and diversity. Moreover, it is unclear whether the use of
frozen fecal contents or cecal contents would confer any difference in the outcomes
of transfer. Herein, groups of mice colonized with distinct gut microbiota of differing
richness and composition were used in a reciprocal FMT study, with different groups
receiving transfer of material prepared from fresh cecal contents, fresh feces, or frozen
feces. Targeted 16S rRNA gene amplicon sequencing was used at intervals throughout
the study to characterize the microbiota. Notably, despite comparable depletion of
the microbiota in recipient mice prior to transfer, donor-specific taxa reliably colonized
recipients only when relatively rich donor material was transferred to mice originally
colonized with a simpler microbiota. It is unclear whether these differences were due
to differences in the endogenous recipient microbiota or host factors induced in early life
by microbial factors. These findings are of practical import for researchers using FMT to
prospectively assess the influence of the gut microbiota in mouse models, and to those
studying host-microbial interactions and their influence on gut barrier function.
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INTRODUCTION
While it has long been appreciated that the microorganisms present in the gastrointestinal tract
(GIT) of free-living animals can affect host health both positively and negatively, it is only
recently that molecular methods have been developed to allow comprehensive characterization of
these communities. Whole genome and targeted sequencing approaches have revealed microbial
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ecosystems within the gut, referred to here as the gut microbiota
(GM), which outnumber host somatic cells by an order of
magnitude. Impressively, the number of distinct genes encoded
by the GM, collectively referred to as the gut microbiome,
exceeds that of the host by greater than two orders of magnitude.
With these comparisons in mind, it may not be surprising that
a constant stream of data demonstrates correlations between
the composition or gene content of the GM and diseases or
conditions affecting not just the GIT (de Vos and de Vos, 2012),
but also the cardiovascular (Tang and Hazen, 2014), endocrine
(Clarke et al., 2014), and central nervous systems (Cryan and
Dinan, 2012). However, the majority of data generated in human
studies provide correlative associations and there is a need for
robust and reproducible model systems in which causality can
be tested. Rodent models are one attractive approach due to
the ability to control for genetics and environmental factors,
many of which can influence the composition or gene expression
of the GM. Moreover, rodent models allow for longitudinal
studies wherein disease can be induced by well-characterized and
uniform triggers.
Experimental manipulation of the GM in rodents can
be performed several different ways (Ericsson and Franklin,
2015), including rederivation via embryo transfer to germ-
free status, rederivation into surrogate hosts harboring defined
GM profiles, co-housing to allow transmission of gut microbes
via coprophagy, and direct inoculation with pure cultures or
complex mixtures of bacteria, the latter referred to as fecal
microbiota transfer (FMT). FMT has gained well-deserved
attention in human medicine as an effective means of treating
antibiotic-induced overgrowth of Clostridium difficile, with
an estimated therapeutic efficacy of 80–90% (Kassam et al.,
2013; Kelly et al., 2014; Youngster et al., 2014a). In this
context, FMT recipients are already subject to significantly
decreased microbial diversity (Chang et al., 2008), typically
owing to antibiotic administration prior to the proliferation of
C. difficile. With experimental FMT using animal models, the
pre-existing GM provides colonization resistance against the
transferred microbiota and a cocktail of antibiotics is typically
administered to animals prior to FMT to minimize this. While
multiple antibiotic regimens have been used for this purpose,
a cocktail comprising ampicillin, vancomycin, neomycin, and
metronidazole has gained favor due to its activity against Gram
positive, Gram negative, and anaerobic bacteria, as well as its
potential oral administration in drinking water.
Of note however, the depletion of autochthonous
bacteria following antibiotic administration is often assessed
via standard microbiological culture in aerobic and anaerobic
conditions (Rakoff-Nahoum et al., 2004; Turer et al., 2008;
Ochoa-Repáraz et al., 2009; Kirkland et al., 2012; Ramanan et al.,
2014; Knoop et al., 2016) or is not evaluated at all (Nemoto
et al., 2009; Koike et al., 2012; Lee et al., 2014). Considering the
recalcitrance of many gut microbes to cultivation ex vivo, the true
efficacy of the aforementioned antibiotic cocktail in depleting
the GM is unclear although one study focusing on this question
indicated that a 7 day exposure was not sufficient to sterilize the
gut (Croswell et al., 2009). Subsequent studies using molecular
methods to assess the post-antibiotic GM in mice have reported
similarly incomplete depletion of commensal gut microbes
(Ichinohe et al., 2011; Dapito et al., 2012; Baldridge et al., 2015;
He et al., 2015; Schuijt et al., 2016). As an extension of this, the
degree to which FMT results in the successful colonization of
recipient animals by donor microbes may also vary. Moreover,
scant empirical data are available comparing the efficacy of
frozen fecal material or fresh cecal contents in FMT. While the
use of frozen feces in FMT would allow for storage and greater
flexibility in experimental procedures, it is possible that freezing
may induce preferential lysis of certain taxa. Alternatively, cecal
contents may represent a preferable source of FMT material
due to its function as a relatively protected nidus of the colonic
microbiota in rodents.
As more laboratories begin to treat the GM as the independent
variable using methods such as administration of antibiotics and
FMT, it will be important to understand the degree to which
these methods result in the removal of the endogenous GM and
repopulation of the GIT with the transplanted GM. Additionally,
there are well-characterized differences in the richness, diversity,
and composition of the GM of mice purchased from different
commercial sources (Ericsson et al., 2015), and the influence
of these differences is also of interest. That is, can FMT fully
reconstitute a mouse that begins with a relatively sparse GMwith
a richer one and, conversely, can a mouse with a relatively rich
GM be reconstituted via FMT with a less rich GM?
To assess the ability of a commonly used antibiotic cocktail
to deplete the GM and allow for the stable transfer of the GM
from con-specific donor animals, reciprocal FMT was performed
between two groups of age-, sex-, and genotype-matched
mice harboring distinct GM profiles with significantly differing
richness and diversity. Samples were collected longitudinally
from all recipient animals and subjected to targeted 16S
rRNA amplicon sequencing and a thorough statistical analysis.
Additionally, separate groups of mice received FMT with fresh
fecal, frozen fecal, or fresh cecal material and colonization of
recipients by donor microbes was similarly compared.
METHODS
Mice
All mice were housed at the Discovery Ridge vivarium at the
University of Missouri, an AAALAC international-accredited
institution, and all procedures were performed under the
approval of the University of Missouri Institutional Animal
Care and Use Committee and according to the guidelines
put forth in the Guide for the Care and Use of Laboratory
Animals. To serve as FMT recipients, twenty-four C57BL/6J
(The Jackson Laboratory, Bar Harbor, ME) and twenty-five
C57BL/6Hsd (Envigo, Indianapolis, IN) 6 week-old, female mice
were purchased and housed in groups of four mice per cage,
in individually ventilated cages (Thoren, Hazleton, PA), under
a 14:10 light cycle. Mice were given irradiated, autoclaved 5,053
mouse chow (LabDiet, St. Louis, MO) and autoclaved, acidified
water ad libitum. Recipient mice were placed in clean cages on
the first day of antibiotic administration, on the first day of
the FMT, and at 2 week intervals thereafter. To serve as donor
mice, six age-matched female C57BL/6J and six C57BL/6Hsd
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mice were purchased, with direction to supply the mice from the
same vendor facility isolators as the recipient mice. Donor mice
were housed three mice per cage in conditions identical to those
described above.
Antibiotic Administration
Following collection of the pre-treatment fecal samples, recipient
mice were administered ampicillin (1 g/L), neomycin (1 g/L),
metronidazole (1 g/L), and vancomycin (500 mg/L) in the
drinking water for 5 consecutive days. Water containing
antibiotics was prepared daily; water bottles were monitored to
confirm consumption and mice were monitored on a daily basis
for signs of dehydration although none were observed.
Fecal Microbiota Transfer (FMT)
For FMT of fresh and frozen fecal material, donor mice were
placed in empty autoclaved cages (no bedding) and allowed
to defecate normally. Donor material was not collected on
an individual mouse basis, but rather from all donor mice
from each vendor concurrently in two collection cages, each
containing three mice. Following collection of a minimum of
twelve fecal pellets per substrain (i.e., vendor) using individual
sterile toothpicks, half of the fecal pellets were placed in a sterile
cryo-vial and immediately placed in a−80◦C freezer (Revco UxF,
Thermo Scientific,Waltham,MA) until used. The other half were
promptly placed in 2 mL round-bottom tubes containing 800
µL autoclaved, filtered water (Milli-Q, EMD Millipore, Billerica,
MA) and homogenized for 1 min at 30 Hz using a TissueLyser II
(Qiagen, Valencia, CA). Homogenates were then passed through
a 30 µm pore-size nylon filters to remove large particulate and
fibrous matter. Fresh fecal slurries were then pooled and diluted
to a volume of 2.5 mL to allow for transfer of 300 µL per mouse
to eight recipients each day. For FMT of frozen fecal material,
samples were removed from the −80◦C freezer, allowed to thaw
for ∼10–15 min, and then processed as described above for
fresh samples. For FMT of cecal material, one mouse from each
substrain (i.e., vendor) was sacrificed each day and the entire
cecal contents of each mouse collected into a 2 mL round-bottom
tubes containing 800 µL autoclaved, filtered water and processed
as described above. Thus, the cecal contents of each donor
mouse was used to inoculate eight recipient mice. Inoculation
was performed via gastric gavage of freshly prepared material on
3 consecutive days, beginning immediately after discontinuation
of antibiotics and placement on untreated drinking water.
Sample Collection
Fecal samples for 16S rRNA amplicon sequencing were collected
as described above with two exceptions. First, mice were
placed individually in empty autoclaved cages and allowed to
defecate. Second, fecal samples were collected directly into 2 mL
round-bottom tubes containing 800 µL lysis buffer, prepared
as previously described (Ericsson et al., 2015). Fecal samples
were collected from all recipient mice at each time-point, i.e.,
prior to antibiotic administration; immediately after the full
antibiotic regimen; and at 1, 2, and 4 weeks post-FMT. See
Supplementary Figure S1.
DNA Extraction
DNA was extracted using a manual nucleic acid precipitation
method, as previously described (Ericsson et al., 2015). Briefly,
samples were placed in a 2 mL round-bottom tube containing
800 µL of lysis buffer and a sterile 0.5 cm diameter stainless
steel bead, and homogenized with a TissueLyser II. Supernatant
was collected, supplemented with 200 µL of 10M ammonium
acetate, and allowed to incubate on ice for 10 min. Following
centrifugation at 16,000 × g for 10 min at room temperature,
supernatant was removed, mixed with an equivalent volume
of isopropanol, and allowed to incubate on ice for 30 min.
Precipitated nucleic acids were then pelleted at 16,000× g for 15
min at 4◦C, rinsed twice with 70% ethanol, resuspended in Tris-
EDTA, and then purified using DNeasy kits (Qiagen) according
to manufacturer’s instructions. DNA yields were measured using
a Qubit 2.0 fluorometer and Qubit dsDNA BR assay kits
(Invitrogen) according to manufacturer’s instructions.
16S rRNA Library Preparation and
Sequencing
All amplification and sequencing were performed at the
University of Missouri DNA Core, as previously described (Hart
et al., 2015). Briefly, normalized DNA was used as template
to generate an amplicon library of the V4 region of the 16S
rRNA gene. Amplicons were generated using single-indexed
(Walters et al., 2011) universal primers (U515F/806R; Caporaso
et al., 2011) flanked by Illumina adapter sequences, and the
following PCR parameters: 98◦C(3 m) + [98◦C(15 s) + 50◦C(30 s)
+ 72◦C(30 s)] × 25 cycles + 72◦C(7 m). Amplicons were pooled
for sequencing using the Illumina MiSeq instrument and V2
chemistry with 2× 250 bp paired-end reads.
Informatics Analysis
All trimming, assembly, binning, and annotation of contiguous
sequences was performed at the University of Missouri
Informatics Research Core Facility, as previously described (Hart
et al., 2015). Briefly, contiguous sequences were assembled using
FLASH software (Magoc and Salzberg, 2011) and removed if
found to be short after trimming for a base quality below
31. Qiime v1.8 software (Kuczynski et al., 2011) was used
to perform de novo and reference-based chimera detection
and removal. Remaining contigs were assigned to operational
taxonomic units (OTUs) via de novo OTU clustering with a
97% nucleotide identity. Selected OTUs were annotated using
BLAST (Altschul et al., 1997) against the Greengenes database
(DeSantis et al., 2006). Principal component analysis (PCA)
of ¼ root-transformed sequence data and α-diversity indices
were performed at the University of Missouri Metagenomics
Center using open access Past 3.13 software (Hammer, 2016),
downloaded on April 2, 2016.
Gram Staining
Freshly evacuated fecal samples were handled using sterile
forceps and rolled across an unused glass microscope slide.
Following brief heat fixation over an open flame, staining was
performed using a commercially available Gram stain kit (Becton
Dickinson), according to the manufacturer’s instructions. Briefly,
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slides were first saturated with crystal violet followed by iodide.
After decolorization with acetone, samples were counterstained
with safranin and allowed to air dry. Slides were examined via
light microscopy to determine whether feces of antibiotic-treated
mice still contained bacterial forms.
Statistical Analysis
Differences in coverage and richness between donors were tested
via t-test or Mann–Whitney rank sum test, depending on the
normality of data. Differences in DNA yields between recipient
strains and between pre- and post-antibiotic samples were tested
via two-way analysis of variance (ANOVA). Differences in the
incidence of depletion of fecal DNA to below the limit of
detection via fluorometry were determined via z-test. Differences
between donor and post-FMT recipient samples in richness and
α-diversity were tested via ANOVA or Kruskal–Wallis ANOVA
on ranks, depending on normality of data as pre-determined
via Shapiro–Wilk normality test. All of the aforementioned
testing was performed using SigmaPlot 12.3 (Systat Software
Inc., San Jose, CA). Differences between donor and recipient
at various time-points in β-diversity were tested using one-
way permutational ANOVA (PERMANOVA) and analysis of
similarity (ANOSIM) of ranked Bray-Curtis distances using Past
3.13 software. Uncorrected p-values below 0.001 were considered
significant. For data generated from all samples except those
collected immediately following the 5-day regimen of antibiotics,
a cut-off of 20,000 high-quality reads was set as the inclusion
criteria in further analysis. For data generated from those samples
collected immediately following antibiotic treatment, samples
yielding greater than 750 reads were included in further analysis.
Availability of Data and Materials
The dataset supporting the conclusions of this article is
available in the National Center for Biotechnology Information
(NCBI) Sequence Read Archive (SRA) repository, BioProject ID
PRJNA350534.
RESULTS
One of the overarching objectives of the present research was to
determine the efficiency of transferring a richer GM into adult
recipient mice harboring a less rich GM, and vice versa. Thus,
the source of mice selected for analysis was based on earlier
studies wherein mice purchased from Harlan Labs (now Envigo)
were found to harbor a significantly richer gut microbiota (GM)
than genetically similar mice from The Jackson Laboratory
(Ericsson et al., 2015). To confirm this previously observed
difference, the number of unique sequences detected in mice
from each source, prior to antibiotic treatment and FMT, was
compared. As the detected richness may be dependent on the
sequencing coverage (i.e., total number of high-quality sequences
detected per sample), this was also compared. Supporting earlier
studies, a significantly greater number of unique sequences
was detected in fecal samples from the C57BL/6Hsd (B6Hsd)
mice relative to feces from C57BL/6J (B6J) mice (p < 0.001,
Mann–Whitney rank sum test). Following annotation and
binning of sequences into OTUs (i.e., groups of sequences
sharing ≥97% nucleotide identity), a similar difference was
detected with B6Hsd and B6J mice harboring a mean (±SEM)
of 61 (±1.0) and 34 (±1.2) OTUs, respectively (p < 0.001,
Mann–Whitney rank sum test; Supplementary Figure S2A).
Interestingly, there was also a significant difference in coverage
between groups although samples from B6J mice actually yielded
higher numbers of high-quality sequences than samples from
B6Hsd mice (p < 0.001, t-test), indicating that the difference
in richness could not be explained by differential coverage
(Supplementary Figure S2B).
To allow colonization with transferred GM, it is necessary to
minimize colonization resistance via depletion of the endogenous
GM with broad spectrum antibiotics. To assess the depletion in
each substrain of mouse following 5 consecutive days of oral
antibiotic administration in the drinking water, Gram stains of
freshly evacuated fecal material were prepared and fecal samples
were again subjected to 16S rRNA sequencing. As expected,
Gram-stained fecal smears prepared from both substrains prior
to antibiotic treatment revealed abundant coccoid and rod-
shaped bacteria with, subjectively, a greater relative proportion
of Gram-positive bacteria. Following 5 days of treatment with
antibiotics in the drinking water, Gram stains revealed a dramatic
reduction in bacterial load in all mice. While a few bacterial
forms (both rod and coccoid) were identified in many of the
Gram-stained fecal smears, the samples were largely devoid of
bacteria in both groups of mice, indicating substantial, but not
complete, depletion of the endogenousmicrobiota of both groups
of recipients.
To determine the composition of the GM prior to and
following administration of antibiotics, extracted DNA was
used as template to generate a library of 16S rRNA amplicons
which were then sequenced. Prior to antibiotic treatment, the
two cohorts shared the same dominant bacterial taxa, including
families S24-7, Lachnospiraceae, Ruminococcaceae, Rikenellaceae,
and order Clostridiales. The B6J mice also harbored substantial
proportions of families Turicibacteraceae, Anaeroplasmataceae,
and Verrucomicrobiaceae, while samples from the B6Hsd mice
contained relatively high levels of microbes in the family
Bacteroidaceae (Figure 1A). Following 5 days of continuous
exposure to antibiotics in the drinking water, the fecal microbiota
profiles all shifted dramatically to one dominated by the families
Enterobacteriaceae, Porphyromonadaceae, Alcaligenaceae,
Bacteroidaceae, and order Bacteroidales. Interestingly, substantial
numbers of sequences were annotated to the presumably plant-
origin taxa Order Streptophyta and family mitochondria (class
Alphaproteobacteria, order Rickettsiales; Figure 1B). Despite
the low DNA yields of several of these samples, all but three
B6J and one B6Hsd post-antibiotic samples generated sufficient
high-quality read counts to be interpreted. Taking into account
all detected OTUs, pre- and post-antibiotic samples from the
two groups of mice were compared using PCA (Figure 1C).
As expected, the samples separated along principal component
1 (PC1; 47.51% variation) according to time-point, suggesting
the greatest amount of variability in the entire dataset could
be explained by treatment with antibiotics. Moreover, samples
from the two groups of mice prior to treatment formed distinct
clusters while there was substantial overlap of the two groups
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FIGURE 1 | Stacked bar charts showing the fecal microbiota detected in C57BL/6J (B6J, n = 22) and C57BL/6Hsd (B6Hsd, n =25) mice before (A) and
immediately after (B) 5 consecutive days of continuous exposure to broad spectrum antibiotics, as determined via 16S rRNA amplicon sequencing and annotated to
the level of family. Dominant families are indicated at right or overlaid on chart and post-treatment samples returning fewer than 750 reads are indicated by a blank
space. Principal component analysis of the samples shown above with shaded circles indicating 95% confidence intervals (C). Operational taxonomic unit-level data
were normalized via quarter root transformation. Legend at right.
of mice post-treatment. Regardless, statistical analysis via
PERMANOVA detected significant differences between all
pairwise comparisons, including B6J and B6Hsd post-antibiotic
samples (Table 1).
Following antibiotic exposure for 5 days, mice were
administered a slurry prepared from fresh feces, frozen feces, or
fresh cecal contents by gastric gavage, prepared from donors from
the reciprocal vendor, i.e., B6J mice received B6Hsd fecal or cecal
material and vice versa. Recipient fecal samples collected at 1,
2, and 4 weeks post-FMT were sequenced and compared to the
profiles of the donor colony. To reduce the expense and burden
of analyzing the individual inocula prepared each successive
day, recipient GM profiles were compared to the pre-treatment
samples of the reciprocal group.
Regarding FMT of freshly prepared B6Hsd fecal microbiota
into B6J recipients, the recipient profiles were largely
indistinguishable from the donors by 1 week post-FMT
(Figure 2A). The profiles did not change appreciably at 2 or 4
weeks post-FMT (Figures 2C,E), suggesting that the transfer was
stably introduced into the recipient mice. Multivariate analysis
using PERMANOVA or ANOSIM both confirmed that while the
pre-treatment B6J recipient profile differed significantly from
the B6Hsd donors and most B6J recipient profiles post-FMT,
the B6Hsd (donor) profile was not found to differ from the
post-FMT recipient profiles (Table 2). A second objective was
to determine whether frozen fecal material could be used for
FMT with the same efficacy as fresh fecal material, as this would
permit researchers to freeze and bank multiple samples for later
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TABLE 1 | Results of PERMANOVA comparing the fecal microbiota of
C57BL/6J and C57BL/6Hsd mice pre- and post-antibiotic treatment.
Pre-abx Pre-abx Post-abx Post-abx
C57BL/6J C57BL/6Hsd C57BL/6J C57BL/6Hsd
Pre-abx C57BL/6J 0.0001 0.0001 0.0001
Pre-abx C57BL/6Hsd 18.03 0.0001 0.0001
Post-abx C57BL/6J 96.23 89.79 0.0001
Post-abx C57BL/6Hsd 73.79 68.88 9.307
Values in the upper right represent p-values, with p < 0.001 in bold; values in the lower
left represent F-values.
use. Additionally, cecal contents were used as the source of
FMT material to test whether those microbial populations might
provide a more uniform inoculum. Notably, frozen fecal samples
and fresh cecal contents both performed comparably to fresh
feces as the sample source for FMT (Figures 2A,C,E; Table 2).
Thus, the post-FMT profile resembled the donors much more
closely than the pre-FMT recipient profiles, suggesting that the
B6J mice were successfully inoculated with the fecal microbiota
of the B6Hsd donors in all experimental groups.
Conversely however, when the B6J donor colony was
compared to B6Hsd recipients before and after FMT, the
FIGURE 2 | Principal component analysis demonstrating compositional differences between fecal microbiota profiles of C57BL/6J (B6J, n = 22) and
C57BL/6Hsd (B6Hsd, n = 25) recipients before fecal microbiota transfer (pre-FMT) and at 1 week (A,B), 2 weeks (C,D), and 4 weeks (E,F) post-FMT with
the reciprocal microbiota, legend at top.
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TABLE 2 | Results of PERMANOVA and ANOSIM comparing the fecal microbiota of C57BL/6Hsd donors or C57BL/6J recipients prior to fecal microbiota
transfer (FMT) and the same C57BL/6J recipients 1 week (1 w), 2 weeks (2 w), and 4 weeks (4 w) post-FMT using fresh feces, frozen feces, or fresh cecal
contents as the source material for FMT.
Comparison PERMANOVA ANOSIM
p-values F-values p-values R-values
B6/Hsd DONORS AND B6/J RECIPIENTS
Donor feces (n = 25) Recipient feces 1 w post-FMT using fresh feces (n = 8) 0.0015 9.53 0.0249 0.202
Recipient feces 2 w post-FMT using fresh feces 0.003 7.64 0.0146 0.2091
Recipient feces 4 w post-FMT using fresh feces 0.0041 6.204 0.0006 0.3327
Donor feces (n = 25) Recipient feces 1 w post-FMT using frozen feces (n = 6) 0.3974 0.8281 0.1372 0.1093
Recipient feces 2 w post-FMT using frozen feces 0.0665 3.066 0.0176 0.2295
Recipient feces 4 w post-FMT using frozen feces 0.0056 5.975 0.0042 0.3335
Donor feces (n = 25) Recipient feces 1 w post-FMT using cecal contents (n = 8) 0.1296 2.001 0.1905 0.07034
Recipient feces 2 w post-FMT using cecal contents 0.0574 2.96 0.1226 0.1098
Recipient feces 4 w post-FMT using cecal contents 0.0228 4.158 0.019 0.2051
Recipient feces pre-FMT(n = 22) Recipient feces 1 w post-FMT using fresh feces (n = 8) 0.0001 14.31 0.0005 0.4912
Recipient feces 2 w post-FMT using fresh feces 0.0001 13.89 0.0003 0.5214
Recipient feces 4 w post-FMT using fresh feces 0.0002 20.53 0.0001 0.7167
Recipient feces pre-FMT (n = 22) Recipient feces 1 w post-FMT using frozen feces (n = 6) 0.0019 8.308 0.0002 0.5629
Recipient feces 2 w post-FMT using frozen feces 0.0007 12.31 0.0001 0.6443
Recipient feces 4 w post-FMT using frozen feces 0.0002 16.55 0.0001 0.6932
Recipient feces pre-FMT (n = 22) Recipient feces 1 w post-FMT using cecal contents (n = 8) 0.0002 12.4 0.0001 0.5983
Recipient feces 2 w post-FMT using cecal contents 0.0001 15.77 0.0001 0.6337
Recipient feces 4 w post-FMT using cecal contents 0.0001 16.48 0.0001 0.6046
Significant p-values indicated in bold.
pre-FMT profiles changed minimally following the procedure
(Figures 2B,D,F). Testing via PERMANOVA and ANOSIM
confirmed that the B6Hsd recipient profiles differed significantly
at all time points post-FMT from the B6J donors (Table 3). When
B6Hsd post-FMT profiles were compared to the pre-existing
fecal microbiota of those colonies, no differences were detected
among any of the mice that received FMT prepared from fresh
B6J feces, or at 1 and 2 weeks post-FMT in mice receiving
FMT prepared from frozen B6J feces. Interestingly, there was
a significant difference between the pre-FMT profile and all
post-FMT time-points in B6Hsd recipients receiving B6J cecal
contents (Table 3). Taken collectively, the above data suggest that
the transfer of fecal microbiota from mice harboring the richer
B6Hsd GM into recipients originally colonized with the simpler
B6J GM was largely successful, while the reciprocal procedure
transferring a simpler GM into mice originally colonized with a
richer GM was much less efficacious.
While PCA and multivariate statistical analysis are useful for
visualizing and testing for differences in the overall microbial
community structure, they may not completely reflect the degree
to which rare microbes were transferred during FMT. Thus,
richness and diversity were compared between donor profiles
and post-FMT recipients at each time-point, and the proportion
of donor taxa transferred to recipients was compared between
groups of mice receiving FMT prepared from the different source
materials. Considering first the transfer of the relatively richer
B6Hsd material into B6J recipients, both richness and diversity,
as measured via number of unique sequences (Figure 3A) and
Chao1 (Figure 3B) and Shannon (Figure 3C) diversity indices,
were largely restored in recipients by 2 weeks post-FMT to
levels comparable to those detected in donor mice. Notably, very
few differences were detected in richness or diversity between
recipient mice receiving FMT prepared from the different source
materials at any given time-point, with the exception of greater
richness at 2 weeks post-FMT in samples frommice that received
FMT prepared from frozen feces relative to mice receiving FMT
prepared from fresh feces.
Conversely, the richness and diversity of B6Hsd recipient
profiles were significantly greater than the donor fecal profiles
at all post-FMT time-points, steadily increasing from 1 to 4
weeks post-FMT and approaching the pre-FMT B6Hsd recipient
levels (Figure 4). These data indicate that, despite the significant
reduction of richness and diversity following antibiotic treatment
to levels below that of even the donor material, all three metrics
quickly rebounded to levels significantly greater than that of the
donor material. Moreover, there was an apparent difference in
the richness and diversity of B6Hsd recipient profiles dependent
on the source of material transferred. Specifically, B6Hsd mice
receiving FMT prepared from frozen feces or cecal contents
demonstrated a trend toward lower richness and diversity at all
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TABLE 3 | Results of PERMANOVA and ANOSIM comparing the fecal microbiota of C57BL/6J donors or C57BL/6Hsd recipients prior to fecal microbiota
transfer (FMT) and the same C57BL/6Hsd recipients 1 week (1 w), 2 weeks (2 w), and 4 weeks (4 w) post-FMT using fresh feces, frozen feces, or fresh
cecal contents as the source material for FMT.
PERMANOVA ANOSIM
p-values F-values p-values R-values
B6/J DONORS AND B6/Hsd RECIPIENTS
Donor feces (n = 24) Recipient feces 1 w post-FMT using fresh feces (n = 8) 0.0004 9.626 0.0001 0.5059
Recipient feces 2 w post-FMT using fresh feces 0.0004 10.6 0.0002 0.5378
Recipient feces 4 w post-FMT using fresh feces 0.0001 12.47 0.0002 0.5522
Donor feces (n = 24) Recipient feces 1 w post-FMT using frozen feces (n = 8) 0.0001 17 0.0001 0.7224
Recipient feces 2 w post-FMT using frozen feces 0.0001 25.23 0.0001 0.7361
Recipient feces 4 w post-FMT using frozen feces 0.0001 22.98 0.0001 0.7342
Donor feces (n = 24) Recipient feces 1 w post-FMT using cecal contents (n = 9) 0.0001 15.56 0.0001 0.6982
Recipient feces 2 w post-FMT using cecal contents 0.0001 21.41 0.0001 0.7943
Recipient feces 4 w post-FMT using cecal contents 0.0001 16.71 0.0001 0.7136
Recipient feces pre-FMT (n = 25) Recipient feces 1 w post-FMT using fresh feces (n = 8) 0.1411 1.945 0.3223 0.03354
Recipient feces 2 w post-FMT using fresh feces 0.0889 2.549 0.0832 0.1204
Recipient feces 4 w post-FMT using fresh feces 0.0481 3.045 0.0277 0.2002
Recipient feces pre-FMT (n = 25) Recipient feces 1 w post-FMT using frozen feces (n = 8) 0.0073 5.056 0.0035 0.2973
Recipient feces 2 w post-FMT using frozen feces 0.0055 6.873 0.0012 0.335
Recipient feces 4 w post-FMT using frozen feces 0.0003 10.71 0.0001 0.5049
Recipient feces pre-FMT (n = 25) Recipient feces 1 w post-FMT using cecal contents (n = 9) 0.0001 10.48 0.0001 0.5381
Recipient feces 2 w post-FMT using cecal contents 0.0001 10.14 0.0001 0.5573
Recipient feces 4 w post-FMT using cecal contents 0.0001 8.241 0.0001 0.4945
Significant p-values indicated in bold.
time-points post-FMT than mice receiving FMT prepared from
fresh feces. Considering the fact that all post-FMT time-points
harbored richer and more diverse communities than the original
donor material, a cause for this potential difference was unclear.
While the pre-existing B6Hsd profiles were much richer than
B6J profiles, there were nonetheless many taxa unique to both
microbial communities. After binning of sequences into OTUs
(i.e., groups of sequences sharing a minimum of 97% nucleotide
identity), a total of 127 different OTUs was initially detected
across both groups, with 20 and 35 of those OTUs detected
exclusively in B6J or B6Hsd mice respectively (Figure 5A). Thus,
one possible explanation for the observed differences in richness
and diversity between B6Hsd recipients receiving the different
source materials is the relatively greater transfer of novel taxa
present in fresh B6J feces relative to the other groups. However,
no differences were detected in the number of novel OTUs
detected in B6Hsd recipients that could be attributed to the FMT
donor material and, in fact, only one novel B6J-origin OTU
was detected in any of the B6Hsd recipient groups (Figure 5B).
Additionally, those novel OTUs were each detected at extremely
low relative abundance in only one mouse at one of the three
post-FMT time-points, collectively suggesting negligible stable
transfer of B6J microbiota to B6Hsd recipients, regardless of
source material.
DISCUSSION
In summary, the data described above suggest that experimental
FMT, when performed using a common antibiotic regimen to
deplete the autochthonous microbiota, may only be effective in
supplementing relatively sparse microbial communities with taxa
from richer sources. The reciprocal procedure, i.e., FMT to re-
populate mice with a less rich and diverse microbial community
than was originally present, evinced negligible transfer regardless
of source material or time-point analyzed post-FMT. One likely
explanation for the rapid return of the fecal microbiota to
a composition matching its original richness and structure
is inadequate depletion of microbes with antibiotics. While
Gram staining indicated that the autochthonous microbiota
had been greatly reduced in both B6J and B6Hsd recipients,
comparison of richness and alpha diversity indices following
antibiotic administration suggested more complete depletion in
the B6J recipients. Thus, the inability to stably transfer the
B6J microbiota into B6Hsd recipients may be a function of
incomplete removal of the pre-existingmicrobiota still occupying
mucosal niches. It is plausible that low numbers of viable
microbes remained in protected niches within the GIT (e.g.,
mucosal biofilms; MacFarlane and Dillon, 2007) throughout
antibiotic treatment, and then rebounded following cessation.
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FIGURE 3 | Bar charts showing the richness (A), Chao1 diversity index (B), and Shannon diversity index (C) of B6Hsd donor fecal profiles, and B6J recipients
prior to any manipulation (pre), immediately after antibiotic treatment (post-abx), and at 1 week (1 w), 2 weeks (2 w), and 4 weeks (4 w) after receiving FMT prepared
from fresh (n = 8) or frozen (n = 6) feces, or fresh cecal contents (n = 8). Dotted line indicates mean value of donor material; like letters indicate significant differences
(p < 0.05, ANOVA). Pre- and post-antibiotic samples included for reference but not included in statistical testing.
While this seems like a logical interpretation for the seeming
reappearance of taxa not detected in the feces of antibiotic-
treated mice, it is worth noting that despite the substantial
(albeit incomplete) depletion of bacteria, very few (if any) of
the B6J-specific microbes were detected in B6Hsd recipients.
One possible explanation is a loss of viability of transferred B6J
microbes during the preparation and administration of the FMT,
although it seems highly unlikely that such a phenomenon would
affect the microbes specific to the B6J GM and not the B6Hsd
GM. Alternatively, the reduced microbial biomass that remained
in B6Hsd recipients following antibiotic treatment was still
capable of eliciting something similar to colonization resistance,
or the GM originally present in the B6Hsd mice induced changes
in the host that were responsible for the observed difference
in transfer of detectable donor-specific taxa, independent of
the antibiotic-induced GM depletion, such as upregulated IgA
or defensin production. Considering that the recipient B6Hsd
mice were likely originally colonized with segmented filamentous
bacteria (Ericsson et al., 2015), which have been shown to
promote colonization resistance against several enteric pathogens
(Garland et al., 1982; Heczko et al., 2000; Ivanov et al., 2009), an
indirect mechanism mediated by GM-induced changes in host
intestinal gene expression is entirely plausible. The concept of
colonization resistance is traditionally put forth in the context
of pathogenic organisms such as enteropathogenic E. coli or
Salmonella enterica, however the underlying mechanisms are
non-specific and could ostensibly limit colonization by resident
microbes in the transferred material. That SFB could play a role is
supported by our historical dataset of endemically SFB-colonized
mice from Envigo (i.e., B6Hsd mice) and a lack of SFB in mice
from the Jackson Laboratory (i.e., B6J mice), and abundant
data linking SFB to significantly enhanced TH17 profiles in
intestinal lymphocytes and, by extension, production of IgA
and broad-spectrum antimicrobial peptides (Buffie and Pamer,
2013). Lastly, there could be genetic differences between the B6J
and B6Hsd substrains contributing to a differential receptivity
to transferred microbes. Multiple groups have documented
substantial genomic differences between the B6 substrains
used in the current study when analyzed using high-density
single-nucleotide polymorphisms (Mekada et al., 2009; Zurita
et al., 2011) and larger structural variants (Yalcin et al., 2011).
Moreover, substrain-dependent phenotypic differences have been
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FIGURE 4 | Bar charts showing the richness (A), Chao1 diversity index (B), and Shannon diversity index (C) of B6J donor fecal profiles, and B6Hsd recipients
prior to any manipulation (pre), immediately after antibiotic treatment (post-abx), and at 1 week (1 w), 2 weeks (2 w), and 4 weeks (4 w) after receiving FMT prepared
from fresh (n = 8) or frozen (n = 8) feces, or fresh cecal contents (n = 9). Dotted line indicates mean value of donor material; like letters indicate significant differences
(p < 0.05, ANOVA). Pre- and post-antibiotic samples included for reference but not included in statistical testing.
reported by several groups, and it is entirely possible that such
differences may have contributed to the differential colonization
of recipient mice in the current study.
It should also be recognized that the antibiotic cocktail
used in the current study was administered in the drinking
water for 5 days, whereas others have used longer durations
of exposure or daily oral gavage of the antibiotics to ensure
delivery. Indeed, a review of the literature reveals several different
antibiotic regimens ranging from a single administration to
induce dysbiosis to 4 weeks of continuous exposure, andwe opted
to use a 5-day duration for two primary reasons. First, even
after 3–4 weeks of continuous exposure to the same antibiotics,
there is incomplete sterilization of the gut (Ichinohe et al., 2011;
Dapito et al., 2012; He et al., 2015; Schuijt et al., 2016). Second,
continuous long-term administration of multiple antibiotics in
the drinking water becomes prohibitively expensive for larger
studies while repeated twice daily oral gavage becomes time- and
labor-intensive. Rather, our goal was to evaluate the feasibility
of manipulating the established GM with minimal burden on
the investigator. It is plausible that the transfer of the B6J GM
into B6Hsd recipients may have been more complete following
longer exposure to antibiotics. Considering however the possible
explanations for the difference in transfer offered above (i.e., loss
of viability during FMT preparation, residual microbes spared
by the antibiotics, or GM-specific effects on host immunity),
additional time exposed to antibiotics would not likely have
increased the efficacy of FMT.
Regarding the use of frozen feces for FMT, the current data
support its ability to serve as the inoculum. No significant
difference was detected in the richness, diversity, or community
structure in recipient mice receiving FMT prepared from frozen
donor feces. One limitation of the current study however was
the relatively short time samples spent in the freezer. It is
possible that longer storage times at −80◦C may negatively
affect the viability of certain taxa for these purposes. That said,
multiple reports have demonstrated comparable clinical efficacy
when treating C. difficile overgrowth via FMT using frozen feces
(Youngster et al., 2014a,b; Lee et al., 2016), providing further
evidence that freezing does not have a substantial negative impact
on the inoculum.
As for FMT using cecal contents, the human cecal microbiota
is reported to harbor a lower abundance of anaerobes relative
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FIGURE 5 | Venn diagram showing the distribution of 127 operational
taxonomic units (OTUs) detected among the C57BL/6J (n = 24) and
C57BL/6Hsd (n = 25) donor colonies pre-FMT (A), and the percentage of
the 20 and 35 OTUs detected exclusively in C57BL/6J and C57BL/6Hsd
donors, respectively, that were detected at any time point post-FMT in the
recipient mice receiving FMT prepared from fresh feces, frozen feces, or cecal
contents (B).
to the feces, while a greater proportion of those anaerobes are
facultative (Marteau et al., 2001). As the cecum of rodents is
a much more distinct anatomic region, we hypothesized that
such differences might be even more pronounced, allowing for
better survival of those microbes during preparation of the FMT.
However, there was again no significant difference detected in
the richness, diversity, or community composition of the fecal
microbiota of mice receiving FMT prepared from cecal contents.
Notably, the cecal contents of recipients were not analyzed and
it is possible that the transfer of cecal microbiota did lead to
differential changes in the cecum and feces of recipient mice.
In conclusion, experimental FMT using the protocol
employed in the present study resulted in successful transfer of
a richer GM harboring SFB into recipient mice starting with
a comparatively less rich, SFB-free GM, while the reciprocal
FMT resulted in negligible change in the recipient GM. The
cause, or causes, for these differences are unclear but are likely
associated with residual GM in the B6/Hsd recipient mice
following antibiotic depletion, or a greater relative abundance
of some host immunological factor involved in resistance to
reconstitution which, in turn, could have been a function of
differences in the pre-existing GM between the two groups.
These findings highlight the need for longitudinal validation in
studies using FMT, particularly in the context of no difference or
change in the dependent variable following FMT. More generally
speaking, the data presented here indicate that transfer of
different gut microbial populations via FMT does not necessarily
produce the same output in recipient mice. Additional studies
will be needed to determine whether the observed differences in
colonization, despite a substantial (albeit incomplete) depletion
of the pre-existing GM, could be exploited as a therapeutic or
prophylactic measure in humans.
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